Literature DB >> 26361798

Mineralocorticoid Receptor Antagonism in AKI: A New Hope?

Luis A Juncos1, Luis I Juncos2.   

Abstract

Entities:  

Keywords:  acute renal failure; aldosterone; nitric oxide

Mesh：

Substances：

Year:  2015        PMID： 26361798      PMCID： PMC4731135          DOI： 10.1681/ASN.2015080866

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  18 in total

Review 1.  The distant organ effects of acute kidney injury.

Authors:  Morgan E Grams; Hamid Rabb
Journal:  Kidney Int       Date:  2011-08-03       Impact factor: 10.612

Review 2.  Nonsteroidal antagonists of the mineralocorticoid receptor.

Authors:  Peter Kolkhof; Christina Nowack; Frank Eitner
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-09       Impact factor: 2.894

3.  Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone.

Authors:  Juan M Mejía-Vilet; Victoria Ramírez; Cristino Cruz; Norma Uribe; Gerardo Gamba; Norma A Bobadilla
Journal:  Am J Physiol Renal Physiol       Date:  2007-03-20

Review 4.  Pathophysiology of ischemic acute kidney injury.

Authors:  Asif A Sharfuddin; Bruce A Molitoris
Journal:  Nat Rev Nephrol       Date:  2011-03-01       Impact factor: 28.314

Review 5.  Promoting Kidney Function Recovery in Patients with AKI Requiring RRT.

Authors:  Jorge Cerdá; Kathleen D Liu; Dinna N Cruz; Bertrand L Jaber; Jay L Koyner; Michael Heung; Mark D Okusa; Sarah Faubel
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-02       Impact factor: 8.237

6.  A new mode of mineralocorticoid receptor antagonism by a potent and selective nonsteroidal molecule.

Authors:  Jérôme Fagart; Alexander Hillisch; Jessica Huyet; Lars Bärfacker; Michel Fay; Ulrich Pleiss; Elisabeth Pook; Stefan Schäfer; Marie-Edith Rafestin-Oblin; Peter Kolkhof
Journal:  J Biol Chem       Date:  2010-07-22       Impact factor: 5.157

7.  Recovery from ischemic acute kidney injury by spironolactone administration.

Authors:  Katy Sánchez-Pozos; Jonatan Barrera-Chimal; Juan Garzón-Muvdi; Rosalba Pérez-Villalva; Roxana Rodríguez-Romo; Cristino Cruz; Gerardo Gamba; Norma A Bobadilla
Journal:  Nephrol Dial Transplant       Date:  2012-04-19       Impact factor: 5.992

8.  Epidemiology of acute kidney injury.

Authors:  Jorge Cerdá; Norbert Lameire; Paul Eggers; Neesh Pannu; Sigehiko Uchino; Haiyan Wang; Arvind Bagga; Adeera Levin
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-23       Impact factor: 8.237

9.  Sulfenic Acid Modification of Endothelin B Receptor is Responsible for the Benefit of a Nonsteroidal Mineralocorticoid Receptor Antagonist in Renal Ischemia.

Authors:  Jonatan Barrera-Chimal; Sonia Prince; Fouad Fadel; Soumaya El Moghrabi; David G Warnock; Peter Kolkhof; Frédéric Jaisser
Journal:  J Am Soc Nephrol       Date:  2015-09-11       Impact factor: 10.121

10.  Adrenalectomy prevents renal ischemia-reperfusion injury.

Authors:  Victoria Ramírez; Joyce Trujillo; Rafael Valdes; Norma Uribe; Cristino Cruz; Gerardo Gamba; Norma A Bobadilla
Journal:  Am J Physiol Renal Physiol       Date:  2009-08-05
View more
  2 in total

1.  New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects.

Authors:  Ana Paula Davel; Iris Z Jaffe; Rita C Tostes; Frederic Jaisser; Eric J Belin de Chantemèle
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-29       Impact factor: 4.733

Review 2.  Finerenone: a New Mineralocorticoid Receptor Antagonist Without Hyperkalemia: an Opportunity in Patients with CKD?

Authors:  Hermann Haller; Anna Bertram; Klaus Stahl; Jan Menne
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.